Fintel reports that on December 15, 2025, BTIG reiterated coverage of Organogenesis Holdings (NasdaqCM:ORGO) with a Buy recommendation. Analyst Price Forecast Suggests 79.50% Upside As of December 6, ...

CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of ...

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But if you buy shares in a really great company, you can more than double ...

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors ...

Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for ...

Scientists at SLAC unexpectedly created gold hydride, a compound of gold and hydrogen, while studying diamond formation under extreme pressure and heat. This discovery challenges gold’s reputation as ...

A 15-year-old student and teacher sustained burns when a fire erupted during a chemistry experiment at Brookline High School’s summer program on July 3. The incident highlights the need for laboratory ...

A new leap in lab automation is shaking up how scientists discover materials. By switching from slow, traditional methods to real-time, dynamic chemical experiments, researchers have created a ...

Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc. At this time, all participants have placed in listen ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only mode.